Sarcopenia in nonalcoholic fatty liver disease and all‐cause and cause‐specific mortality in the United States

Diet quality and its association with nonalcoholic fatty liver disease and all‐cause and cause‐specific mortality

(2020) Eric R. Yoo et al.   LIVER INTERNATIONAL

Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA

(2019) Karn Wijarnpreecha et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease

(2019) Andrew A. Li et al.   Gut and Liver

Sarcopenia

(2019) Alfonso J Cruz-Jentoft et al.   LANCET

Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity

(2019) Karn Wijarnpreecha et al.   MATURITAS

Impact of sarcopenia on the progression of nonalcoholic fatty liver disease: a frequently forgotten association

(2019) Andrew A. Li et al.   Hepatobiliary Surgery and Nutrition

Impact of sarcopenia on 1-year mortality in older patients with cancer

(2018) Lindsey Otten et al.   AGE AND AGEING

Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis

(2017) Rahima A. Bhanji et al.   HEPATOLOGY

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis

(2017) Bo Kyung Koo et al.   JOURNAL OF HEPATOLOGY

Sarcopenia as a predictor of all-cause mortality among community-dwelling older people: A systematic review and meta-analysis

(2017) Ping Liu et al.   MATURITAS

Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease

(2016) S. Petta et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Review article: sarcopenia in cirrhosis - aetiology, implications and potential therapeutic interventions

(2016) M. Sinclair et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011)

(2016) Yong-ho Lee et al.   HEPATOLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Accuracy of a predictive bioelectrical impedance analysis equation for estimating appendicular skeletal muscle mass in a non-Caucasian sample of older people

(2015) Diana Beatriz Rangel Peniche et al.   ARCHIVES OF GERONTOLOGY AND GERIATRICS

Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008–2011)

(2015) Yong-ho Lee et al.   JOURNAL OF HEPATOLOGY

Impact of muscle wasting on survival in patients with liver cirrhosis

(2015) Maria Kalafateli   WORLD JOURNAL OF GASTROENTEROLOGY

Skeletal muscle mass in hospitalized elderly patients: Comparison of measurements by single-frequency BIA and DXA

(2013) Ingvar Bosaeus et al.   CLINICAL NUTRITION

Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 randomized trial)

(2013) Elisabetta Bacchi et al.   HEPATOLOGY

Relationship between sarcopenia and nonalcoholic fatty liver disease: The Korean Sarcopenic Obesity Study

(2013) Ho Cheol Hong et al.   HEPATOLOGY

Accuracy of Specific BIVA for the Assessment of Body Composition in the United States Population

(2013) Roberto Buffa et al.   PLoS One

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

(2012) Donghee Kim et al.   HEPATOLOGY

Association of leisure-time physical activity with cognition by apolipoprotein-E genotype in persons aged 60 years and over: the National Health and Nutrition Examination Survey (NHANES-III)

(2012) Thomas Obisesan et al.   Clinical Interventions in Aging

The Epidemiology of Sarcopenia

(2011) Ian Janssen   CLINICS IN GERIATRIC MEDICINE

Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss

(2011) K. Hallsworth et al.   GUT

Prevalence and Determinant Factors of Sarcopenia in Patients With Type 2 Diabetes: The Korean Sarcopenic Obesity Study (KSOS)

(2010) T. N. Kim et al.   DIABETES CARE

Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease

(2010) P. Loria et al.   DIGESTIVE AND LIVER DISEASE

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Amy G. Shah et al.   Clinical Gastroenterology and Hepatology